Please contact our sales team for your Consulting and Customization queries/concerns at [email protected].
Equine rabies immunoglobulin (ERIG) cheaper than human rabies immune globulin (HRIG), so for patients in developing countries (such as India), and prices are more affordable.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Equine Rabies Immunoglobulin (ERIG) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Equine Rabies Immunoglobulin (ERIG) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Equine Rabies Immunoglobulin (ERIG) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Equine Rabies Immunoglobulin (ERIG) include Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Equine Rabies Immunoglobulin (ERIG) manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Equine Rabies Immunoglobulin (ERIG) market. Further, it explains the major drivers and regional dynamics of the global Equine Rabies Immunoglobulin (ERIG) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- Serum China
- Lanzhou Institute of Biological Products
- Wuhan Institute of Biological Products
- Premium Serums
- Haffkine Bio-Pharmaceutical
- Bharat Serums
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Equine Rabies Immunoglobulin (ERIG) Segment by Type
- 1500IU
- 1000IU
- 400IU
- Other
Equine Rabies Immunoglobulin (ERIG) Segment by Application
- Category II Exposure
- Category III Exposure
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - China Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Equine Rabies Immunoglobulin (ERIG) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Equine Rabies Immunoglobulin (ERIG), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Equine Rabies Immunoglobulin (ERIG), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Equine Rabies Immunoglobulin (ERIG), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Equine Rabies Immunoglobulin (ERIG) sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Equine Rabies Immunoglobulin (ERIG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Equine Rabies Immunoglobulin (ERIG) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, etc.
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market Segment by Application
1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size (2017-2028)
2.1.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue (2017-2028)
2.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales (2017-2028)
2.2 Global Equine Rabies Immunoglobulin (ERIG) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Regions (2017-2022)
2.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Regions (2017-2022)
2.3 Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Region
2.3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2023-2028)
2.3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2023-2028)
2.4 Global Top Equine Rabies Immunoglobulin (ERIG) Regions (Countries) Ranking by Market Size
2.5 Equine Rabies Immunoglobulin (ERIG) Market Dynamics
2.5.1 Equine Rabies Immunoglobulin (ERIG) Market Trends
2.5.2 Equine Rabies Immunoglobulin (ERIG) Market Drivers
2.5.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
2.5.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Equine Rabies Immunoglobulin (ERIG) Manufacturers by Sales (2017-2022)
3.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2017-2022)
3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Equine Rabies Immunoglobulin (ERIG) Sales in 2021
3.2 Global Top Manufacturers Equine Rabies Immunoglobulin (ERIG) by Revenue
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2017-2022)
3.2.2 Top Equine Rabies Immunoglobulin (ERIG) Manufacturers Covered: Ranking by Revenue
3.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Equine Rabies Immunoglobulin (ERIG) Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2021)
3.4 Global Equine Rabies Immunoglobulin (ERIG) Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Equine Rabies Immunoglobulin (ERIG) Market
3.7 Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Type
4.1 Global Equine Rabies Immunoglobulin (ERIG) Historic Market Review by Type (2017-2022)
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2022)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2022)
4.1.3 Equine Rabies Immunoglobulin (ERIG) Price by Type (2017-2022)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2023-2028)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Type (2023-2028)
4.2.3 Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2023-2028)
5 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Application
5.1 Global Equine Rabies Immunoglobulin (ERIG) Historic Market Review by Application (2017-2022)
5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2022)
5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2022)
5.1.3 Equine Rabies Immunoglobulin (ERIG) Price by Application (2017-2022)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2023-2028)
5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Application (2023-2028)
5.2.3 Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Company
6.1.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022)
6.1.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022)
6.2 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
6.2.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
6.2.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
6.3 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
6.3.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
6.3.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
6.4 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
6.4.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
6.4.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Company
7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022)
7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022)
7.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Type
7.2.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
7.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
7.3 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Application
7.3.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
7.3.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
7.4 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country
7.4.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
7.4.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Company
8.1.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022)
8.1.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022)
8.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Type
8.2.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
8.2.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
8.3 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Application
8.3.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
8.3.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
8.4 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Region
8.4.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region
8.4.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Company
9.1.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022)
9.1.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022)
9.2 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
9.2.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
9.2.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
9.3 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
9.3.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
9.3.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
9.4 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
9.4.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
9.4.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Breakdown by Company
10.1.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022)
10.1.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022)
10.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Type
10.2.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
10.2.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
10.3 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Application
10.3.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
10.3.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
10.4 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country
10.4.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
10.4.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Serum China
11.1.1 Serum China Corporation Information
11.1.2 Serum China Overview
11.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Products and Services
11.1.5 Serum China Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
11.1.6 Serum China Recent Developments
11.2 Lanzhou Institute of Biological Products
11.2.1 Lanzhou Institute of Biological Products Corporation Information
11.2.2 Lanzhou Institute of Biological Products Overview
11.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Products and Services
11.2.5 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
11.2.6 Lanzhou Institute of Biological Products Recent Developments
11.3 Wuhan Institute of Biological Products
11.3.1 Wuhan Institute of Biological Products Corporation Information
11.3.2 Wuhan Institute of Biological Products Overview
11.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Products and Services
11.3.5 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
11.3.6 Wuhan Institute of Biological Products Recent Developments
11.4 Premium Serums
11.4.1 Premium Serums Corporation Information
11.4.2 Premium Serums Overview
11.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Products and Services
11.4.5 Premium Serums Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
11.4.6 Premium Serums Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Corporation Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Products and Services
11.5.5 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
11.5.6 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Bharat Serums
11.6.1 Bharat Serums Corporation Information
11.6.2 Bharat Serums Overview
11.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Products and Services
11.6.5 Bharat Serums Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
11.6.6 Bharat Serums Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Equine Rabies Immunoglobulin (ERIG) Value Chain Analysis
12.2 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
12.4 Equine Rabies Immunoglobulin (ERIG) Sales and Marketing
12.4.1 Equine Rabies Immunoglobulin (ERIG) Sales Channels
12.4.2 Equine Rabies Immunoglobulin (ERIG) Distributors
12.5 Equine Rabies Immunoglobulin (ERIG) Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 1500IU
Table 3. Major Manufacturers of 1000IU
Table 4. Major Manufacturers of 400IU
Table 5. Major Manufacturers of Other
Table 6. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022) & (Kiloton)
Table 9. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2017-2022)
Table 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2017-2022)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2023-2028) & (Kiloton)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Equine Rabies Immunoglobulin (ERIG) Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Equine Rabies Immunoglobulin (ERIG) Market Trends
Table 18. Equine Rabies Immunoglobulin (ERIG) Market Drivers
Table 19. Equine Rabies Immunoglobulin (ERIG) Market Challenges
Table 20. Equine Rabies Immunoglobulin (ERIG) Market Restraints
Table 21. Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2017-2022) & (Kiloton)
Table 22. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers (2017-2022)
Table 23. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Equine Rabies Immunoglobulin (ERIG) Manufacturers by Revenue (US$ Million) in 2021
Table 25. Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2017-2022)
Table 26. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2021)
Table 28. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Average Selling Price (ASP) & (2017-2022) & (US$/Ton)
Table 29. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Plants/Factories Distribution
Table 30. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Area Served
Table 31. Date of Key Manufacturers Enter into Equine Rabies Immunoglobulin (ERIG) Market
Table 32. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Type (2017-2022)
Table 35. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2017-2022)
Table 36. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Equine Rabies Immunoglobulin (ERIG) Price (Kiloton) by Type (2017-2022)
Table 38. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Type (2023-2028)
Table 39. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2023-2028)
Table 40. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2023-2028)
Table 42. Global Equine Rabies Immunoglobulin (ERIG) Price (Kiloton) by Type (2023-2028)
Table 43. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Application (2017-2022)
Table 44. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2017-2022)
Table 45. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Price (Kiloton) by Application (2017-2022)
Table 47. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Application (2023-2028)
Table 48. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2023-2028)
Table 49. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2023-2028)
Table 51. Global Equine Rabies Immunoglobulin (ERIG) Price (Kiloton) by Application (2023-2028)
Table 52. North America Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022) & (Kiloton)
Table 53. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2017-2022)
Table 54. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2017-2022)
Table 56. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (Kiloton)
Table 57. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (Kiloton)
Table 58. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (Kiloton)
Table 61. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (Kiloton)
Table 62. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (Kiloton)
Table 65. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (Kiloton)
Table 66. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022) & (Kiloton)
Table 69. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2017-2022)
Table 70. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2017-2022)
Table 72. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (Kiloton)
Table 73. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (Kiloton)
Table 74. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (Kiloton)
Table 77. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (Kiloton)
Table 78. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (Kiloton)
Table 81. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (Kiloton)
Table 82. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022) & (Kiloton)
Table 85. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (Kiloton)
Table 89. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (Kiloton)
Table 90. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (Kiloton)
Table 93. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (Kiloton)
Table 94. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022) & (Kiloton)
Table 97. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2023-2028) & (Kiloton)
Table 98. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022) & (Kiloton)
Table 101. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2017-2022)
Table 102. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2017-2022)
Table 104. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (Kiloton)
Table 105. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (Kiloton)
Table 106. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (Kiloton)
Table 109. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (Kiloton)
Table 110. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (Kiloton)
Table 113. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (Kiloton)
Table 114. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2022) & (Kiloton)
Table 117. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2022) & (Kiloton)
Table 121. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2023-2028) & (Kiloton)
Table 122. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2022) & (Kiloton)
Table 125. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2023-2028) & (Kiloton)
Table 126. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2022) & (Kiloton)
Table 129. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2023-2028) & (Kiloton)
Table 130. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2023-2028) & (US$ Million)
Table 132. Serum China Corporation Information
Table 133. Serum China Description and Overview
Table 134. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 135. Serum China Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 136. Serum China Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 137. Serum China Recent Developments
Table 138. Lanzhou Institute of Biological Products Corporation Information
Table 139. Lanzhou Institute of Biological Products Description and Overview
Table 140. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 141. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 142. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 143. Lanzhou Institute of Biological Products Recent Developments
Table 144. Wuhan Institute of Biological Products Corporation Information
Table 145. Wuhan Institute of Biological Products Description and Overview
Table 146. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 147. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 148. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 149. Wuhan Institute of Biological Products Recent Developments
Table 150. Premium Serums Corporation Information
Table 151. Premium Serums Description and Overview
Table 152. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 153. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 154. Premium Serums Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 155. Premium Serums Recent Developments
Table 156. Haffkine Bio-Pharmaceutical Corporation Information
Table 157. Haffkine Bio-Pharmaceutical Description and Overview
Table 158. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 159. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 160. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 161. Haffkine Bio-Pharmaceutical Recent Developments
Table 162. Bharat Serums Corporation Information
Table 163. Bharat Serums Description and Overview
Table 164. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2017-2022)
Table 165. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 166. Bharat Serums Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 167. Bharat Serums Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 171. Equine Rabies Immunoglobulin (ERIG) Customers List
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Rabies Immunoglobulin (ERIG) Product Picture
F
|
Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2023
Equine rabies immunoglobulin (ERIG) cheaper than human rabies immune globulin (HRIG), so for patients in developing countries (such as India), and prices are more affordable. Highlights The global Equine Rabies Immunoglobulin (ERIG) mar... |
|
Global Equine Rabies Immunoglobulin (ERIG) Market Insights, Forecast to 2029
Equine rabies immunoglobulin (ERIG) cheaper than human rabies immune globulin (HRIG), so for patients in developing countries (such as India), and prices are more affordable. The global Equine Rabies Immunoglobulin (ERIG) market is projected t... |
|
Global and Japan Equine Rabies Immunoglobulin (ERIG) Market Insights, Forecast to 2027
Equine Rabies Immunoglobulin (ERIG) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Equine Rabies Immunoglobulin (ERIG) market will be able to gain the upper h... |
|
Global Equine Rabies Immunoglobulin (ERIG) Market Insights, Forecast to 2028
Equine Rabies Immunoglobulin (ERIG) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Equine Rabies Immunoglobulin (ERIG) market will be able to gain the upper hand as they use the report as a... |
|
(Post-pandemic Era) - Global Equine Rabies Immunoglobulin (ERIG) Market Segment Research Report 2022
Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really rec... |
|
Post-pandemic Era - Global Equine Rabies Immunoglobulin (ERIG) Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really rec... |
|
Equine Rabies Immunoglobulin (ERIG) Market, Global Outlook and Forecast 2022-2028
Equine rabies immunoglobulin (ERIG) cheaper than human rabies immune globulin (HRIG), so for patients in developing countries (such as India), and prices are more affordable. This report contains market size and forecasts of Equine Rabie... |
|
Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2021
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme... |
|
Global Equine Rabies Immunoglobulin (ERIG) Sales Market Report 2021
Equine rabies immunoglobulin (ERIG) cheaper than human rabies immune globulin (HRIG), so for patients in developing countries (such as India), and prices are more affordable. Market Analysis and Insights: Global Equine Rabies Immunoglo... |
|
Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2020
Equine rabies immunoglobulin (ERIG) cheaper than human rabies immune globulin (HRIG), so for patients in developing countries (such as India), and prices are more affordable. Since the COVID-19 virus outbreak in December 2019, the dise... |
